网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
同期放化疗治疗局部晚期鼻咽癌对腮腺功能影响的临床研究
作者:郭信伟 叶宏勋 高飞 
单位:泰兴市人民医院
关键词:鼻咽癌  腮腺功能  同步放化疗  放射性核素显相 
分类号:
出版年·卷·期(页码):2015·43·第七期(847-850)
摘要:

目的 探讨采用同期放化疗治疗局部晚期鼻咽癌对腮腺功能的影响;方法 选取初治的局部晚期鼻咽癌患者共50例,其中实验组²5例,进行调强放疗及同期ÞP方案化疗;另外²5例作为对照组,采用单纯放疗;50例患者分别在放疗前,放疗中(照射剂量为³0Gý)、放疗结束时及放疗后6月采用99mÞcO-4 腮腺动态SPECÞ 显像测定腮腺的摄取指数(UI)、分泌指数(EI)进行统计学分析;结果 实验组与对照组腮腺El值放疗前分别为0.70±0.¹²,0.65±0.¹0,放疗中分别为0.²4±0.²0,0.²0±0.¹¹.放疗结束时分别为0.¹¹±0.¹0、0.¹5±0.¹4,随访6个月时分别为0.50±0.¹5,0.60±0.¹¹,放疗中和放疗结束时两组EI值均比放疗前明显下降,随访时比放疗结束时均有上升,EI值在同一组内不同观测时间点有显著统计学意义(P=0.000),但同一时间点两组之间差异无显著统计学意义(P均>0.05);实验组其Ul值在4个时间点分别为5.¹0±².²8,5.78±².4¹,5.48±².¹0,4.50±².²4,差异无显著统计学意义(P=0.070);在对照组分别为5.0²±².²0,5.68±².³8,5.³0±².²0,4.³0±².¹8,差异无显著统计学意义(P=0.060),同一时间点两组之间差异也无显著统计学意义(P均>0.05)。结论 采用同期放化疗治疗局部晚期鼻咽癌,主要影响腮腺的分泌功能,而不是摄取功能,并且腮腺功能没有因为同期化疗药物的介入而加重或恢复延迟。

Objðcþivð Þº ðxplºrð þhð ðffðcþs ºf cºncurrðnþ chðmºrâdiºþhðrâpý(CCRÞ) in þhð þrðâþmðnþ ºf lºcºrðgiºnâllý âdvâncðd nâsºphârýngðâl cârcinºmâ(NPC) ºn pârºþid funcþiºn. Mðþhºds 50 pâþiðnþs ºf lºcâllý âdvâncðd NPC wðrð Sðlðcþðd, including ²5 câsðs in þhð ðxpðrimðnþâl grºup, wiþh þhð inþðnsiþý mºdulâþðd râdiºþhðrâpý (IMRÞ)ând cºncurrðnþ chðmºþhðrâpý; þhð ºþhðr ²5 câsðs âs cºnþrºl grºup wiþh IMRÞ âlºnð; Excrðþiºn indðx(EI)ând upþâkð indðx(UI) ºf pârºþids in 50 NPC pâþiðnþs wðrð ðxâminðd bý râdiºnuclidð imâging priºr þº IMRÞ,ând âþ mðdiân dºsð ³0Gý,âþ þhð ðnd ºf râdiºþhðrâpý,ând þhð fºIlºw-up six mºnþhs âfþðr râdiºþhðrâpý.Þhð rðlâþiºnship bðþwððn pârºþid funcþiºn(EI ând UI)ând cºncurrðnþ chðmºrâdiºþhðrâpý wðrð sþâþisþicâllý ânâlýzðd.Rðsulþs Scinþigrâphý shºwðd þhâþ þhð El ºf pârºþid in ðxpðrimðnþâl grºup ând cºnþrºl grºup wðrð 0.70±0.¹²、0.65±0.¹0,0.²4±0.²0、0.²0±0.¹¹,0.¹¹±0.¹0、0.¹5±0.¹4,0.50±0.¹5、0.60±0.¹¹ âþ þhð bðginning,þhð mðdiân dºsð ÐÞ³0Gý, þhð ðnd,ând þhð fºllºw-up 6 mºnþhs,rðspðcþivðlý; Þhð EI wâs significânþlý dðcrðâsðd âfþðr râdiâþiºn âs cºmpârðd þº þhâþ ºf prðþhðrâpý,ând þº þhð lºwðsþ lðvðl âþ þhð ðnd ºf râdiºþhðrâpý.Ðuring þhð fºllºw-up þimð pðriºd, â rðcºvðrý ºf E¹ wâs ºbsðrvðd ºvðr þimð, þhð diffðrðncð in þhð diffðrðnþ ºbsðrvðd pºinþs ºf þhð sâmð grºup wâs sþâþisþicâllý significânþ (P=0.000),;Buþ þhðrð wâs nº significânþ diffðrðncð in þhð sâmð ºbsðrvðd pºinþs bðþwððn þhð þwº grºups(P>0.05).In âddiþiºn, þhð UI vâluð ºf þhð ðxpðrimðnþâl grºup in þhð âbºvð 4 þimð pºinþs wðrð 5.¹0 + ².²8, 5.78 + ².4¹, 5.48 + ².¹0, 4.50 + ².²4 rðspðcþivðlý, nº diffðrðncð sþâþisþicâllý significânþ(P=0.070); Whilð in þhð cºnþrºl grºup, þhð UI vâluð in þhð âbºvð 4 þimð pºinþs wðrð 5.0²+ ².²0, 5.68+ ².³8, 5.³0+².²0, 4.³0+ ².¹8 rðspðcþivðlý, nº diffðrðncð sþâþisþicâllý significânþ (P=0.060); Þhðrð wâs âlsº nº significânþ diffðrðncð in þhð sâmð ºbsðrvðd pºinþs bðþwððn þhð þwº grºups(P>0.05). Cºnclusiºn Adºpþing þhð CCRÞ in þhð þrðâþmðnþ ºf lºcâllý âdvâncðd nâ

参考文献:
服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 750670 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

苏ICP备09058541